Biden meets with COVID team on Omicron variant, is told we won't know its threat profile for 2 weeks
A lot of the concerns public health experts have for the newly identified Omicron variant of the COVID-19 coronavirus stem from what they don't know. From the World Health Organization on down, health officials stress it will be weeks before we know how transmissible, deadly, and able to evade current COVID-19 protections the strain proves to be. Omicron was first detected in South Africa, and the WHO labeled it a "variant of concern" on Friday.
"We need more data there before we can say confidently that this is not a severe version of the virus, but we should find that out in the next couple weeks," outgoing National Institutes of Health Director Dr. Francis Collins told Fox News Sunday.
Dr. Anthony Fauci, a top medical adviser to President Biden, told Biden on Sunday he expects it will be about two weeks before we have definitive information on the Omicron strain and its risk profile, according to a White House readout of Biden's Oval Office meeting with his COVID-19 response team.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Omicron has already been detected in Canada, Australia, Britain, France, Germany, Belgium, the Netherlands, Hong Kong, Israel, Italy, Botswana, and South Africa. Biden's coronavirus advisers said they expect the Omicron variant to reach the U.S., if it hasn't already, despite a travel ban on eight southern African countries set to take effect Monday, the White House said.
The White House COVID team's recommendation for Americans is that all vaccinated adults get a booster shot and unvaccinated adults and eligible children to get immunized as soon as possible. Fauci told Biden he believes existing vaccines provide at least "a degree of protection against severe cases of COVID."
Outside experts agreed. "If you're worried about Omicron, do the same things as if you're worried about Delta: Get your boost and get fully vaccinated," Peter Hotez, dean of the National School of Tropical Medicine at Houston's Baylor College of Medicine, told The Washington Post.
About 24 percent of South Africans are fully vaccinated, versus 60 percent of Americans, according to Johns Hopkins data. Fauci told NBC News on Sunday that "whether or not we're headed into a bleak or bleaker winter is really going to depend upon what we do" with the time South African officials gave us. He called Omicron "a clarion call" to get vaccinated or boosted and elaborated on why he thinks that will protect people against the new variant.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
China and India's dam war in the Himalayas
Under The Radar Delhi's response to Beijing's plans for a huge dam in Tibet? Build a huge dam of its own right nearby
By Chas Newkey-Burden, The Week UK Published
-
Born this way
Opinion 'Born here, citizen here' is the essence of Americanism
By Mark Gimein Published
-
What does Trump's immigration crackdown mean for churches?
Today's Big Question Mass deportations come to 'sacred spaces'
By Joel Mathis, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
How close are we to a norovirus vaccine?
Today's Big Question A new Moderna trial raises hopes of vanquishing a stomach bug that sickens millions a year
By David Faris Published
-
HMPV is spreading in China but there's no need to worry
The Explainer Respiratory illness is common in winter
By Devika Rao, The Week US Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published
-
Dark chocolate tied to lower diabetes risk
Speed Read The findings were based on the diets of about 192,000 US adults over 34 years
By Peter Weber, The Week US Published
-
ACA opens 2025 enrollment, enters 2024 race
Speed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
By Peter Weber, The Week US Published